Pharmaceutical Equipment Validation Services

The standard stages are Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). DQ confirms the design meets the user requirements before anything is built or installed. IQ verifies the equipment arrived and was set up correctly. OQ confirms it operates as intended across its full operating range. PQ goes one step further, demonstrating that the equipment consistently delivers acceptable results under real production conditions. Some organizations also include Factory Acceptance Testing (FAT) and Site Acceptance Testing (SAT) before IQ begins.

The main regulation is 21 CFR Part 211, which requires that manufacturing equipment be appropriately designed, adequately sized, and consistently maintained. Validation is expected to produce documented protocols and reports showing the equipment performs within its intended parameters. The FDA's 2011 Process Validation Guidance adds a lifecycle lens to this, covering process design, qualification, and continued process verification rather than treating validation as a one-time project. If computerized systems are involved, 21 CFR Part 11 also applies.

The main frameworks are 21 CFR Part 211 for finished pharmaceuticals, EU GMP Annex 15 for qualification and validation, ICH Q7 for active pharmaceutical ingredients, and GAMP 5 for any computerized components. Medical device manufacturers follow 21 CFR Part 820 instead. Calibration is typically governed by ISO 17025 or the relevant USP chapters depending on the instrument. For organizations looking to streamline compliance across all of these requirements, life sciences process optimization services can help standardize and automate how validation workflows are managed.